A61P 11 - Drugs for disorders of the respiratory system

Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
12/2004
12/09/2004	US20040248944 Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
12/09/2004	US20040248936 such as (R)-1-{4-[4-(4-Phenoxy-2-propyl-phenoxy)-butoxy]-benzenesulfonyl}-azetidine-2-carboxylic acid, used as peroxisome proliferator-activated receptor agonists; hypoglycemic agents
12/09/2004	US20040248924 Compositions for treatment of common cold
12/09/2004	US20040248923 Novel 4-anilinoquinoline-3-carboxamides
12/09/2004	US20040248920 Spiro-hydantoin compounds useful as anti-inflammatory agents
12/09/2004	US20040248897 Substituted N-acylaniline derivatives, the preparation thereof, and their use as pharmaceutical compositions
12/09/2004	US20040248889 Analgesics; synthesis
12/09/2004	US20040248787 fusion protein comprising a PTD (protein transduction domain) and an MITF (microphthalmia-associated transcripution factor) variant as an active ingredient with a His tag
12/09/2004	US20040248769 hydrolytic; inhibits arginyl endopeptidase or serine protease activity; air cleaner; fabric treatment
12/09/2004	US20040248252 Nucleotide sequences coding mammalian histamine H4 receptor protein for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders
12/09/2004	US20040248233 Using propyl hydroxylase expression system to identify modulators which interfere with or prevent generation of hypoxic states; screening modulator for treatment and prevention of cell proliferative and thrombotic disorder
12/09/2004	US20040248188 Methods for using tetanus toxin for benificial purposes in animals (mammals)
12/09/2004	US20040248173 Nucleotide sequences coding cyclic peptide receptor for use in identifying modulators for treatment of pituitary hormone, epinephrine release, gastrointestinal, cardiovascular, electrolyte balance, hypertensive, diabetic and respiratory system disorder
12/09/2004	US20040247628 Kit for the preparation of a pharmaceutical composition
12/09/2004	US20040247606 Treatment of sinusitis related chronic facial pain and headache with botulinum toxin injections
12/09/2004	US20040247530 Pharmaceutical composition comprising salmeterol and budesonide for the treatment of respitory disorders
12/09/2004	US20040247529 Administering a pulmonary surfactant preparation, including a phosphatide and/or a surfactant protein to artificially respirate a patient suffering from a toxic oxygen concentration; side effect reduction
12/09/2004	US20040246627 Disc drive pivot bearing assembly
12/09/2004	US20040244794 Inhalation device with a pharmaceutical composition
12/09/2004	CA2526623A1 Soluble clca-1 and antagonists to clca-1
12/09/2004	CA2525839A1 Crystalline form of .beta.2 adrenergic receptor agonist
12/08/2004	EP1484402A2 Antibody for use in therapy
12/08/2004	EP1484333A1 New aminopropylphosphonous acids
12/08/2004	EP1484332A2 Lipid-based drug delivery system for administration of a drug substance
12/08/2004	EP1484320A1 Jnk inhibitor
12/08/2004	EP1483284A2 Selective dipeptide inhibitors of kallikrein
12/08/2004	EP1483266A1 Spiro compounds with npy antagonistic activity
12/08/2004	EP1483242A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
12/08/2004	EP1483231A1 Novel cinnamate salts, method for production and use thereof as medicaments
12/08/2004	EP1483228A1 Nk1 antagonists
12/08/2004	EP1482984A2 Surrogate antibodies and methods of preparation and use thereof
12/08/2004	EP1482973A1 Methods of modulating cd200 receptors
12/08/2004	EP1482972A2 Treatment of immunological disorders using anti-cd30 antibodies
12/08/2004	EP1482962A2 Method of treating trx mediated diseases
12/08/2004	EP1482955A1 Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
12/08/2004	EP1482951A1 Alpha-hydroxy-2-methylene-10-nor-pregnacalciferol and its uses
12/08/2004	EP1482942A2 Stabilized pharmaceutical compositions of halofuginone and other quinazolinone derivatives
12/08/2004	EP1482941A1 Beta-sheet mimetics and composition and methods relating thereto
12/08/2004	EP1482940A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
12/08/2004	EP1482938A1 Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist
12/08/2004	EP1482937A2 Novel tyloindicines and related processes, pharmaceutical compositions and methods
12/08/2004	EP1482931A2 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/08/2004	EP1482928A2 Mediators of hedgehog signaling pathways,compositions and uses related thereto
12/08/2004	EP1482926A2 Amino-methyl substituted tetracycline compounds
12/08/2004	EP1482918A2 Utilization of ubiquinones for influencing the effect of histamine
12/08/2004	EP1482896A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
12/08/2004	EP1482895A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
12/08/2004	EP1363898A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/08/2004	EP1341754B1 Substituted anthranilic acids
12/08/2004	EP1305286B1 Cyclopentanoindoles, compositions containing such compounds and methods of treatment
12/08/2004	EP1303290A4 Small peptides and methods for downregulation of ige
12/08/2004	EP1240152B1 Ox(adi)azolyl-hydroxamic acids useful as procollagen c-proteinase inhibitors
12/08/2004	EP1220856B1 Pyrazolo[4,3-d]pyrimidine derivatives
12/08/2004	EP1127052B1 Substituted 2-phenylbenzimidazoles, the production thereof and their use
12/08/2004	CN1553806A Use of SAPR-1 for the treatment and/or prevention of scleroderma
12/08/2004	CN1553804A Combinations for the treatment of inflammatory disorders
12/08/2004	CN1553801A Inhalation compositions comprising tricyclic 5,6-dihydro-9H-pyrazolo (3,4-C)-1,2,4-triazolo (4,3-alpha) pyridines
12/08/2004	CN1553799A Dosage forms having prolonged active ingredient release
12/08/2004	CN1552731A Use and clone expression of coronavirus phosphorylated nucleoprotein of SARS
12/08/2004	CN1552725A Preparation of solanine sulfurate and its use in medicine
12/08/2004	CN1552724A Preparation of solanine and its use in medicine
12/08/2004	CN1552707A 4-aryl group-5H-thoifuran-2-ketone derivative, producing method and use thereof
12/08/2004	CN1552690A Benzyl ethylene quininate derivatives, their preparations and uses
12/08/2004	CN1552443A Lysozyme injection preparation
12/08/2004	CN1552442A Interferon nasal spray powder with long service for detoxication and anti-bacteria
12/08/2004	CN1552433A Chinese medicine preparation for treating respiratory tract infection and virus flu, preparing method thereof
12/08/2004	CN1552425A Water snowflake extract, preparation and use thereof
12/08/2004	CN1552420A Use of pilose asiabell and astragalus composition in preventing and treatnig acute pulmonary hurt
12/08/2004	CN1552413A Internal medicine for treating SARS, AIDS virus, preparing method and use thereof
12/08/2004	CN1552405A Clearing heat and detoxicating medicine
12/08/2004	CN1552402A Clearing lung and stopping Asthma medicine and preparing process thereof
12/08/2004	CN1552396A Detoxicating Chinese medicine decoction for treating SARS
12/08/2004	CN1552395A Chinese medicine preparation for preventing SARS virus
12/08/2004	CN1552394A Chinese medicine powder for treating SARS virus in mask
12/08/2004	CN1552393A Analgesic and detoxicating Chinese medicine powder for treating SARS
12/08/2004	CN1552392A Chinese medicinal preparation for treatnig cough and asthma caused by SARS
12/08/2004	CN1552391A Anti-inflammation and antipyretic medicine for treating SARS
12/08/2004	CN1552390A Freeing lung medicine for treating SARS
12/08/2004	CN1552389A Detoxicating medicine for preventing and treating SARS
12/08/2004	CN1552388A Clearing heat and detoxicating medicine for treating SARS
12/08/2004	CN1552387A Clearing heat and freeing lung medicine for treating SARS
12/08/2004	CN1552384A Yilingjing pills and their preparation
12/08/2004	CN1552380A Four season three-yellow micro-pills and their preparation
12/08/2004	CN1552363A Pungent rhinitis pills and their preparation
12/08/2004	CN1552329A Powder injection of cefpiramide
12/08/2004	CN1552325A Doxofyline osmotic pump controlled releasing preparation and its production
12/08/2004	CN1552321A Use of Abidol in preparing medicines for treating and preventing SARS virus
12/08/2004	CN1178955C Modified TNF alpha molecules and DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA
12/08/2004	CN1178940C Selective antagonists of A28 adenosine receptors
12/08/2004	CN1178932C Amide derivatives
12/08/2004	CN1178931C Substituted pyrazole compounds
12/08/2004	CN1178923C 1,4-diazepan-2,5-dione derivatives and their use as NK-1 receptor antagonists
12/08/2004	CN1178922C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
12/08/2004	CN1178917C N-oxides as NK1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
12/08/2004	CN1178905C Novel peptide derivative
12/08/2004	CN1178679C Medicine for curing asthma, chronic acid acute bronchitis and pulmonary emphysema
12/08/2004	CN1178677C Buccal cordyceps lozenge and its preparing process
12/08/2004	CN1178656C Pharmaceutical composition
12/07/2004	US6828456 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
12/07/2004	US6828447 Therapeutic agent for use in the treatment of cardiovascular and inflammatory disorders

1 ... 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 ... 878